ESC 365 - Early Rhythm-Control Therapy and High Comorbidity Burden.

ESC Professional Premium Access

Early Rhythm-Control Therapy and High Comorbidity Burden.

Session: Latest science in atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Dickow (Hamburg, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Jannis Dickow

Asklepios St. Georg Clinic, Hamburg (Germany)

1 presentation

0 follower

3 more presentations in this session

The LOOP Study - Stroke severity and etiology in patients screened for atrial fibrillation versus usual care

Speaker: Doctor S. Diederichsen (Copenhagen, DK)

Predictors and mediators of improved outcomes on early rhythm control an analysis of the EAST AFNET - 4 data set.

Speaker: Professor L. Eckardt (Muenster, DE)

Mortality and characteristics among four DOACs and warfarin.

Speaker: Associate Professor M. Kuwabara (Shimotsuke, JP)

Access the full session

Latest science in atrial fibrillation

Speakers: Doctor J. Dickow, Doctor S. Diederichsen, Professor L. Eckardt, Associate Professor M. Kuwabara

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources